See more : Endurance Acquisition Corp. (EDNC) Income Statement Analysis – Financial Results
Complete financial analysis of C.I. Medical Co.,Ltd. (3540.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of C.I. Medical Co.,Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Sichuan Zhongguang Lightning Protection Technologies Co., Ltd. (300414.SZ) Income Statement Analysis – Financial Results
- Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) Income Statement Analysis – Financial Results
- Big Tech 50 R&D-Limited Partnership (BIGT.TA) Income Statement Analysis – Financial Results
- Hubei Kailong Chemical Group Co., Ltd. (002783.SZ) Income Statement Analysis – Financial Results
- Polytec Holding AG (0GOX.L) Income Statement Analysis – Financial Results
C.I. Medical Co.,Ltd. (3540.T)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.ci-medical.co.jp
About C.I. Medical Co.,Ltd.
C.I. Medical Co.,Ltd. designs, manufactures, and sells dental care products in Japan. The company offers tooth brushes; and other dental care products through mail order sales. It also provides milling machines, scanners, and software solutions to dental facilities, as well as deals in dental clinical products, including high-tech dental machines. The company serves medical cooperatives, dental clinics, dental associations, health centers, dental colleges, hospitals, veterinary clinics, nursing and care facilities, and dental dealers. C.I. Medical Co.,Ltd. was incorporated in 2000 and is headquartered in Hakusan, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 45.63B | 42.89B | 41.21B | 37.39B | 28.76B |
| Cost of Revenue | 33.63B | 31.22B | 29.60B | 26.10B | 21.01B |
| Gross Profit | 12.00B | 11.67B | 11.61B | 11.29B | 7.75B |
| Gross Profit Ratio | 26.29% | 27.22% | 28.16% | 30.20% | 26.95% |
| Research & Development | 27.00M | 14.00M | 19.00M | 18.00M | 16.00M |
| General & Administrative | 5.94B | 4.74B | 4.17B | 3.80B | 4.00B |
| Selling & Marketing | 3.06B | 2.94B | 2.92B | 2.79B | 1.65B |
| SG&A | 9.00B | 7.68B | 7.08B | 6.59B | 5.65B |
| Other Expenses | 0.00 | 53.00M | 49.00M | 53.00M | 0.00 |
| Operating Expenses | 9.01B | 7.68B | 7.08B | 6.59B | 5.64B |
| Cost & Expenses | 42.64B | 38.90B | 36.68B | 32.69B | 26.65B |
| Interest Income | 37.00M | 31.00M | 21.00M | 25.00M | 30.43M |
| Interest Expense | 17.00M | 6.00M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.02B | 396.00M | 345.00M | 271.00M | 288.00M |
| EBITDA | 4.01B | 4.39B | 4.87B | 4.97B | 2.39B |
| EBITDA Ratio | 8.80% | 10.38% | 12.59% | 14.16% | 8.30% |
| Operating Income | 2.99B | 3.99B | 4.52B | 4.70B | 2.10B |
| Operating Income Ratio | 6.55% | 9.30% | 10.98% | 12.57% | 7.30% |
| Total Other Income/Expenses | 195.00M | -139.00M | -238.00M | -252.00M | 48.00M |
| Income Before Tax | 3.18B | 3.85B | 4.29B | 4.45B | 2.15B |
| Income Before Tax Ratio | 6.98% | 8.98% | 10.40% | 11.90% | 7.47% |
| Income Tax Expense | 1.08B | 1.33B | 1.46B | 1.53B | 643.00M |
| Net Income | 2.08B | 2.52B | 2.82B | 2.92B | 1.51B |
| Net Income Ratio | 4.56% | 5.88% | 6.84% | 7.81% | 5.23% |
| EPS | 41.64 | 50.43 | 56.40 | 58.40 | 30.10 |
| EPS Diluted | 41.64 | 50.43 | 56.40 | 58.40 | 30.10 |
| Weighted Avg Shares Out | 50.00M | 50.00M | 50.00M | 50.00M | 50.00M |
| Weighted Avg Shares Out (Dil) | 50.00M | 50.00M | 50.00M | 50.00M | 50.00M |
Source: https://incomestatements.info
Category: Stock Reports